References
- Plumb K . Continuous processing in the pharmaceutical industry – changing the mindset.Chem. Eng. Res. Design83, 730–738 (2005).
- Pollet P , CopeED, KassnerMKet al. Production of (S)-1-benzyl-3-diazo-2-oxopropylcarbamic acid tert-butyl ester, a diazoketone pharmaceutical intermediate, employing a small scale continuous reactor. Indust. Eng. Chem. Res. 48, 7032–7036 (2009).
- Constable DJC , Jiménez-GonzálezC, HendersonRK. Perspective on solvent use in the pharmaceutical industry.Org. Process Res. Dev.11, 133–137 (2007).
- Vervaet C , RemonJP. Continuous granulation in the pharmaceutical industry.Chem. Eng. Sci.60, 3949–3957 (2005).
- Behr A , BrehmeVA, EwersCLJet al. New developments in chemical engineering for the production of drug substances. Eng. Life Sci. 4, 15–24 (2004).
- Löbbecke S , FerstlW, PanićS, TürckeT. Concepts for modularization and automation of microreaction technology.Chem. Eng. Technol.28, 484–493 (2005).
- Hartman RL , JensenKF. Microchemical systems for continuous-flow synthesis.Lab Chip9, 2495–2507 (2009).
- Hartman RL , NaberJR, BuchwaldSL, JensenKF. Multistep microchemical synthesis enabled by microfluidic distillation.Angew. Chem. Int. Ed. Engl.49, 899–903 (2010).
- Roberge DM , DucryL, BielerN, CrettonP, ZimmermannB. Microreactor technology: a revolution for the fine chemical and pharmaceutical industries?Chem. Eng. Technol.28, 318–323(2005).
- Stonestreet P , HarveyAP. A mixing-based design methodology for continuous oscillatory flow reactors.Chem. Eng. Res. Design80, 31–44 (2002).
- Browne DL , DeadmanBJ, AsheR, BaxendaleIR, LeySV. Continuous flow processing of slurries: evaluation of an agitated cell reactor.Org. Proc. Res. Dev.15, 693–697(2011).
- Christensen KM , PedersenMJ, Dam-JohansenK, HolmTL, SkovbyT, KiilS. Design and operation of a filter reactor for continuous production of a selected pharmaceutical intermediate.Chem. Eng. Sci.71, 111–117 (2012).
- Gernaey KV , Cervera-PadrellAE, WoodleyJM. A perspective on PSE in pharmaceutical process development and innovation.Comput. Chem. Eng.42, 15–29 (2012).
- Sin G , ÖdmanP, PetersenN, Eliasson Lantz A, Gernaey KV. Matrix notation for efficient development of first-principles models within PAT applications: integrated modeling of antibiotic production with Streptomyces coelicolor. Biotechnol. Bioeng.101, 153–171 (2008).
- Samad NAF , SinghR, SinG, GernaeyKV, GaniR. A generic multi-dimensional model-based system for batch cooling crystallization processes.Comput. Chem. Eng.35, 828–843 (2011).
- Singh R , Rozada-SanchezR, WrateTet al. A retrofit strategy to achieve “Fast, Flexible, Future (F3)” pharmaceutical production processes. Comput. Aid. Chem. Eng. 29, 291–295 (2011).
Websites
- US FDA. Guidance for Industry. PAT – a framework for innovative pharmaceutical development, manufacturing and quality assurance. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070305.pdf
- PricewaterhouseCoopers. Pharma 2020: virtual R&D. Which path will you take? www.pwc.com/pharma